Twin Tree Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12M Buy
+86,300
New +$12.1M 0.25% 63
2025
Q2
Sell
-28,500
Closed -$3.19M 1738
2025
Q1
$3.19M Sell
28,500
-16,300
-36% -$1.68M 0.01% 1029
2024
Q4
$4.14M Sell
44,800
-338,500
-88% -$30.5M 0.01% 981
2024
Q3
$32.1M Sell
383,300
-601,800
-61% -$45.9M 0.06% 274
2024
Q2
$67.6M Sell
985,100
-369,400
-27% -$24.7M 0.15% 128
2024
Q1
$99.2M Buy
+1,354,500
New +$104M 0.22% 85
2023
Q4
Sell
-343,700
Closed -$25.8M 1443
2023
Q3
$25.8M Sell
343,700
-2,300
-0.7% -$177K 0.06% 288
2023
Q2
$26.7M Sell
346,000
-29,900
-8% -$2.38M 0.04% 338
2023
Q1
$31.2M Buy
+375,900
New +$31.1M 0.06% 283
2022
Q4
Sell
-915,400
Closed -$56.5M 1395
2022
Q3
$56.5M Buy
915,400
+525,400
+135% +$33.1M 0.11% 158
2022
Q2
$24.1M Sell
390,000
-20,200
-5% -$1.25M 0.04% 355
2022
Q1
$24.4M Sell
410,200
-19,700
-5% -$1.26M 0.04% 402
2021
Q4
$31.2M Buy
429,900
+239,000
+125% +$16.5M 0.07% 278
2021
Q3
$13.3M Buy
+190,900
New +$13.4M 0.03% 492
2021
Q2
Sell
-91,300
Closed -$5.9M 1448
2021
Q1
$5.9M Sell
91,300
-35,600
-28% -$2.3M 0.02% 605
2020
Q4
$7.39M Sell
126,900
-75,300
-37% -$4.54M 0.03% 515
2020
Q3
$12.8M Hold
202,200
0.05% 379
2020
Q2
$15.6M Buy
+202,200
New +$15.5M 0.06% 345
2019
Q2
Sell
-73,100
Closed -$4.75M 1355
2019
Q1
$4.75M Sell
73,100
-47,300
-39% -$3.14M 0.02% 457
2018
Q4
$7.53M Buy
120,400
+73,100
+155% +$5.11M 0.05% 392
2018
Q3
$3.65M Sell
47,300
-129,700
-73% -$9.8M 0.02% 461
2018
Q2
$12.5M Buy
177,000
+46,800
+36% +$3.3M 0.08% 222
2018
Q1
$9.82M Buy
130,200
+58,300
+81% +$4.63M 0.08% 214
2017
Q4
$5.15M Sell
71,900
-139,200
-66% -$10.6M 0.04% 388
2017
Q3
$17.1M Buy
211,100
+10,600
+5% +$811K 0.14% 153
2017
Q2
$14.2M Buy
200,500
+154,400
+335% +$10.3M 0.11% 178
2017
Q1
$3.13M Buy
46,100
+4,100
+10% +$288K 0.03% 455
2016
Q4
$3.01M Buy
+42,000
New +$3.12M 0.03% 512
2016
Q3
Sell
-53,500
Closed -$4.46M 1218
2016
Q2
$4.46M Sell
53,500
-46,200
-46% -$4.1M 0.07% 285
2016
Q1
$9.16M Buy
99,700
+84,100
+539% +$7.58M 0.17% 121
2015
Q4
$1.58M Sell
15,600
-82,700
-84% -$8.61M 0.03% 485
2015
Q3
$9.65M Buy
98,300
+32,000
+48% +$3.55M 0.25% 56
2015
Q2
$7.76M Buy
66,300
+20,800
+46% +$2.27M 0.19% 101
2015
Q1
$4.46M Buy
45,500
+21,100
+86% +$2.14M 0.11% 199
2014
Q4
$2.3M Sell
24,400
-116,900
-83% -$12.1M 0.06% 341
2014
Q3
$15M Sell
141,300
-34,600
-20% -$3.39M 0.4% 30
2014
Q2
$14.6M Buy
175,900
+158,400
+905% +$12.3M 0.33% 38
2014
Q1
$1.24M Sell
17,500
-31,500
-64% -$2.47M 0.03% 569
2013
Q4
$3.68M Buy
49,000
+23,300
+91% +$1.62M 0.09% 245
2013
Q3
$1.62M Sell
25,700
-31,200
-55% -$1.86M 0.05% 367
2013
Q2
$2.92M Buy
+56,900
New +$2.97M 0.11% 210

Other funds holding GILD

Twin Tree Management's GILD Position: Q4 2024 in Review

Twin Tree Management sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 513,621 shares — an estimated $46.2M sold.

Twin Tree Management first reported a position in GILD in Q3 2013 and held it in 37 quarters. The position peaked at $43.1M in Q3 2024. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Twin Tree Management reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • Twin Tree Management sold 513,621 Gilead Sciences shares in Q4 2024, an estimated $46.2M.
  • Twin Tree Management first reported a position in Gilead Sciences in Q3 2013 and held it in 37 quarters.
  • Twin Tree Management's Gilead Sciences position peaked at $43.1M in Q3 2024.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Twin Tree Management's 13F filing for Q4 2024, filed 10 Feb 2025.